Yayın:
Doxorubicin cardiotoxicity: Growing importance

dc.contributor.buuauthorOrhan, Bülent
dc.contributor.departmentTıp Fakültesi
dc.date.accessioned2021-07-30T07:58:17Z
dc.date.available2021-07-30T07:58:17Z
dc.date.issued1999
dc.identifier.citationOrhan, B. (1999). "Doxorubicin cardiotoxicity: Growing importance". Journal of Clinical Oncology, 17(7), 2294-2295.
dc.identifier.doi10.1200/JCO.1999.17.7.2293c
dc.identifier.endpage2295
dc.identifier.issn0732-183X
dc.identifier.issue7
dc.identifier.pubmed10561289
dc.identifier.startpage2294
dc.identifier.urihttps://doi.org/10.1200/JCO.1999.17.7.2293c
dc.identifier.urihttp://hdl.handle.net/11452/21335
dc.identifier.volume17
dc.identifier.wos000081264300047
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherW B Saunders Co
dc.relation.journalJournal of Clinical Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOncology
dc.subjectContinuous intravenous-infusion
dc.subjectBreast-cancer
dc.subjectReduced cardiotoxicity
dc.subjectTherapy
dc.subjectSchedule
dc.subject.wosOncology
dc.titleDoxorubicin cardiotoxicity: Growing importance
dc.typeLetter
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi
local.indexed.atPubMed

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama